Aplastic Anaemia Clause Samples
The 'Aplastic Anaemia' clause defines the specific circumstances under which a diagnosis of aplastic anaemia is recognized for the purposes of an insurance policy or contract. Typically, this clause outlines the medical criteria that must be met, such as confirmation by a specialist and evidence of bone marrow failure resulting in certain blood deficiencies. Its core function is to ensure that only severe, medically verified cases of aplastic anaemia are eligible for coverage or benefits, thereby preventing ambiguity and potential misuse of the policy.
Aplastic Anaemia. Chronic persistent bone marrow failure, confirmed by biopsy, which results in anaemia, neutropenia and thrombocytopenia requiring treatment with at least one of the following: • Blood product transfusion; • Marrow stimulating agents; • Immunosuppressive agents; or • Bone marrow transplantation. The diagnosis must be confirmed by a haematologist.
Aplastic Anaemia. A Chronic persistent bone marrow failure which results in total aplasia of the bone marrow and requires treatment with at least one of the following:
a) Regular blood product transfusion
b) Marrow stimulating agents
c) Immunosuppressive agents
d) Bone marrow transplantation The diagnosis and suggested line of treatment must be confirmed by a Haematologist using relevant laboratory investigations including Bone Marrow Biopsy. Two out of the following three values should be present:
1. Absolute Neutrophil count of 500 per cubic millimetre or less;
2. Absolute Reticulocyte count of 20,000 per cubic millimetre or less; and
3. Platelet count of 20,000 per cubic millimetre or less.
Aplastic Anaemia. I) Chronic persistent bone marrow failure which results in anaemia, neutropenia and thrombocytopenia requiring treatment with at least one of the following:
i) Blood product transfusion;
ii) Marrow stimulating agents;
iii) Immunosuppressive agents; or
iv) Bone marrow transplantation.
II) The diagnosis must be confirmed by a haematologist using relevant laboratory investigations including Bone Marrow Biopsy resulting in bone marrow cellularity of less than 25% which is evidenced by any two of the following:
i) Absolute neutrophil count of 500/mm³ or less
ii) Platelets count less than 20,000/mm³ or less
iii) Absolute Reticulocyte count of 20,000/mm³ or less
III) Temporary or reversible Aplastic Anaemia is excluded.
IV) In this condition, the bone marrow fails to produce sufficient blood cells or clotting agents.
Aplastic Anaemia. Chronic Irreversible persistent bone marrow failure which results in Anaemia, Neutropenia and Thrombocytopenia requiring treatment with at least TWO of the following:
I. Regular blood product transfusion;
II. Marrow stimulating agents;
III. Immunosuppressive agents; or
IV. Bone marrow transplantation. The diagnosis and suggested line of treatment must be confirmed by a Hematologist acceptable to the Company using relevant laboratory investigations, including bone-marrow biopsy. Two out of the following three values should be present:
I. Absolute neutrophil count of 500 per cubic millimeter or less;
II. Absolute erythrocyte count of 20 000 per cubic millimeter or less; and
III. Platelet count of 20 000 per cubic millimeter or less. Temporary or reversible aplastic anaemia is excluded.
Aplastic Anaemia. Chronic persistent bone marrow failure which results in anaemia, neutropenia and thrombocytopenia requiring treatment with at least one of the following:
a. Blood product transfusion;
b. Marrow stimulating agents;
c. Immunosuppressive agents; or
d. Bone marrow transplantation. The diagnosis must be confirmed by a haematologist using relevant laboratory investigations including Bone Marrow Biopsy resulting in bone marrow cellularity of less than 25% which is evidenced by any two of the following:
a. Absolute neutrophil count of 500/mm³ or less
b. Platelets count less than 20,000/mm³ or less
c. Absolute Reticulocyte count of 20,000/mm³ or less Temporary or reversible Aplastic Anaemia is excluded. In this condition, the bone marrow fails to produce sufficient blood cells or clotting agents.
Aplastic Anaemia. Chronic persistent bone marrow failure which results in anaemia, neutropenia and thrombocytopenia requiring treatment with at least one of the following:
a. Blood product transfusion;
b. Marrow stimulating agents;
c. Immunosuppressive agents; or
d. Bone marrow transplantation. The diagnosis must be confirmed by a haematologist using relevant laboratory investigations including Bone Marrow Biopsy resulting in bone marrow cellularity of less than 25% which is evidenced by any two of the following:
a. Absolute neutrophil count of 500/mm³ or less b. Platelets count less than 20,000/mm³ or less
Aplastic Anaemia. Chronic persistent bone marrow failure which results in anaemia, neutropenia and thrombocytopenia requiring treatment with at least one of the following:
Aplastic Anaemia. Chronic persistent bone marrow failure which results in anaemia, neutropenia and thrombocytopenia requiring treatment with at least one of the following:
a. Blood product transfusion;
b. Marrow stimulating agents;
c. Immunosuppressive agents; or ManipalCigna Lifestyle Protection - Critical Care | Terms & Conditions | UIN: MCIHLIP21125V022021 | October 2021
d. Bone marrow transplantation. The diagnosis must be confirmed by a haematologist using relevant laboratory investigations including Bone Marrow Biopsy resulting in bone marrow cellularity of less than 25% which is evidenced by any two of the following -
a) Absolute neutrophil count of less than 500/mm³ or less
b) Platelets count less than 20,000/mm³ or less
c) Reticulocyte count of less than 20,000/mm³ or less Temporary or reversible Aplastic Anaemia is excluded.
Aplastic Anaemia. Unequivocal diagnosis of bone marrow failure confirmed by a specialist and evidenced by the result of bone marrow biopsy. Disease must result in anaemia, neutropenia and thrombocytopenia and must require treatment with at least one of the following:
a) blood product transfusion
b) marrow stimulating agents
c) immunosuppressive agents
d) bone marrow transplantation